Better Therapeutics Seeks FDA Approval For First Digital Therapeutic For Type 2 Diabetes
Better Therapeutics Inc (NASDAQ:BTTX) has submitted a de novo classification request to the FDA seeking approval for BT-001 digital therapeutic designed to…
Morgan Stanley Maintains Equal-Weight on First Solar, Raises Price Target to $146
Morgan Stanley analyst Stephen Byrd maintains First Solar (NASDAQ:FSLR) with a Equal-Weight and raises the price target from $136 to $146.
Morgan Stanley Maintains Equal-Weight on Duke Energy, Lowers Price Target to $121
Morgan Stanley analyst Stephen Byrd maintains Duke Energy (NYSE:DUK) with a Equal-Weight and lowers the price target from $123 to $121.
Morgan Stanley Maintains Overweight on DTE Energy, Lowers Price Target to $139
Morgan Stanley analyst Stephen Byrd maintains DTE Energy (NYSE:DTE) with a Overweight and lowers the price target from $141 to $139.
Jefferies Maintains Buy on NuCana, Lowers Price Target to $3
Jefferies analyst Eun Yang maintains NuCana (NASDAQ:NCNA) with a Buy and lowers the price target from $21 to $3.
Why Novavax Stock Is Trading Lower Today
Novavax Inc (NASDAQ: NVAX) shares are trading lower Thursday following bearish analyst coverage from JPMorgan.
Morgan Stanley Maintains Overweight on CenterPoint Energy, Lowers Price Target to $33
Morgan Stanley analyst Stephen Byrd maintains CenterPoint Energy (NYSE:CNP) with a Overweight and lowers the price target from $34 to $33.
